DE69433161D1 - O6-substituierte guaninederivate, verfahren zu ihre herstellung und ihre anwendung für behandlung von tumorzellen - Google Patents

O6-substituierte guaninederivate, verfahren zu ihre herstellung und ihre anwendung für behandlung von tumorzellen

Info

Publication number
DE69433161D1
DE69433161D1 DE69433161T DE69433161T DE69433161D1 DE 69433161 D1 DE69433161 D1 DE 69433161D1 DE 69433161 T DE69433161 T DE 69433161T DE 69433161 T DE69433161 T DE 69433161T DE 69433161 D1 DE69433161 D1 DE 69433161D1
Authority
DE
Germany
Prior art keywords
heterocyclic ring
treatment
production
application
tumor cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69433161T
Other languages
English (en)
Other versions
DE69433161T2 (de
Inventor
Thomas Brian Mcmurry
Robert Stanley Mcelhinney
Joan Elizabeth Mccormick
Rhoderick Hugh Elder
Jane Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9410421A external-priority patent/GB9410421D0/en
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Publication of DE69433161D1 publication Critical patent/DE69433161D1/de
Application granted granted Critical
Publication of DE69433161T2 publication Critical patent/DE69433161T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69433161T 1993-06-08 1994-06-08 O6-substituierte guaninederivate, verfahren zu ihre herstellung und ihre anwendung für behandlung von tumorzellen Expired - Fee Related DE69433161T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IE930432 1993-06-08
IE930432 1993-06-08
GB9410421A GB9410421D0 (en) 1993-06-08 1994-05-23 O (six)-substituted guanine derivatives
GB9410421 1994-05-23
PCT/IE1994/000031 WO1994029312A1 (en) 1993-06-08 1994-06-08 O6-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells

Publications (2)

Publication Number Publication Date
DE69433161D1 true DE69433161D1 (de) 2003-10-23
DE69433161T2 DE69433161T2 (de) 2004-07-08

Family

ID=26304937

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69433161T Expired - Fee Related DE69433161T2 (de) 1993-06-08 1994-06-08 O6-substituierte guaninederivate, verfahren zu ihre herstellung und ihre anwendung für behandlung von tumorzellen

Country Status (19)

Country Link
EP (1) EP0702683B8 (de)
JP (1) JP4054057B2 (de)
CN (1) CN1048493C (de)
AT (1) ATE250060T1 (de)
AU (1) AU697977B2 (de)
CA (1) CA2164847C (de)
CZ (1) CZ290951B6 (de)
DE (1) DE69433161T2 (de)
DK (1) DK0702683T3 (de)
ES (1) ES2207638T3 (de)
FI (1) FI955906A (de)
HU (1) HU217779B (de)
NO (1) NO313331B1 (de)
NZ (1) NZ266527A (de)
PL (1) PL180681B1 (de)
PT (1) PT702683E (de)
RU (1) RU2154646C2 (de)
SK (1) SK282621B6 (de)
WO (1) WO1994029312A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043228A (en) * 1993-06-08 2000-03-28 Cancer Research Campaign Technology Limited O6 -substituted guanine derivatives, a process for their preparation and their use in treating tumor cells
US5929046A (en) * 1994-06-08 1999-07-27 Cancer Research Campaign Technology Limited Pyrimidine and purine derivatives and their use in treating tumour cells
US5525606A (en) 1994-08-01 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
DE19618727C2 (de) * 1996-05-09 2000-02-17 Deutsches Krebsforsch Herstellung alkylierter Nucleosid-3'-Phosphate
WO1998042352A1 (en) * 1997-03-24 1998-10-01 Glaxo Group Ltd. Method for treating b-cell tumors with ara-g nucleoside derivatives
ATE311884T1 (de) * 1997-07-12 2005-12-15 Cancer Rec Tech Ltd Cyclin-abhängige-kinase inhibierende purinderivate
US6060458A (en) * 1998-02-13 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use
DE60237792D1 (de) * 2001-04-10 2010-11-04 Ecole Polytech Verfahren zur Verwendung von O6-Alkylguanin-DNS Alkyltransferasen
US6984389B2 (en) * 2002-04-25 2006-01-10 University Of Connecticut Health Center Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
WO2003090686A2 (en) 2002-04-25 2003-11-06 University Of Connecticut Health Center Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
CA2566424A1 (en) * 2004-05-12 2005-11-17 Bayer Cropscience Gmbh Plant growth regulation
CN100350975C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 抗癌药物组合物
GB0502573D0 (en) * 2005-02-08 2005-03-16 Topotarget As Therapeutic compounds
GB0907551D0 (en) * 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN104031048B (zh) * 2014-05-28 2016-03-09 北京工业大学 一种β-氯乙基亚硝基脲类化合物及其合成方法和用途
CN104031047B (zh) * 2014-05-28 2016-03-09 北京工业大学 一种具有抗癌活性的氯乙基亚硝基脲及其合成方法
CN107098906B (zh) * 2017-05-19 2020-05-05 四川大学 苄基鸟嘌呤衍生物及其有机盐类化合物和药物组合物及其应用
CA3091027A1 (en) 2018-02-02 2019-08-08 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2139107A1 (de) * 1971-08-04 1973-02-15 Merck Patent Gmbh Heterocyclisch substituierte adenosinverbindungen
US5352669A (en) * 1990-03-13 1994-10-04 The Of The United States Of America As Represented By The Department Of Health And Human Services O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity

Also Published As

Publication number Publication date
CN1145622A (zh) 1997-03-19
EP0702683A1 (de) 1996-03-27
FI955906A (fi) 1996-02-02
NO954985L (no) 1996-02-07
NO954985D0 (no) 1995-12-07
FI955906A0 (fi) 1995-12-08
SK154795A3 (en) 1996-07-03
AU6805994A (en) 1995-01-03
CZ290951B6 (cs) 2002-11-13
RU2154646C2 (ru) 2000-08-20
NO313331B1 (no) 2002-09-16
DK0702683T3 (da) 2004-02-02
HU9503522D0 (en) 1996-02-28
PL180681B1 (pl) 2001-03-30
HU217779B (hu) 2000-04-28
AU697977B2 (en) 1998-10-22
CN1048493C (zh) 2000-01-19
ATE250060T1 (de) 2003-10-15
JPH08511773A (ja) 1996-12-10
HUT74574A (en) 1997-01-28
CZ323395A3 (en) 1996-06-12
EP0702683B1 (de) 2003-09-17
WO1994029312A1 (en) 1994-12-22
PL311950A1 (en) 1996-03-18
DE69433161T2 (de) 2004-07-08
ES2207638T3 (es) 2004-06-01
PT702683E (pt) 2004-01-30
EP0702683B8 (de) 2004-09-08
CA2164847A1 (en) 1994-12-22
NZ266527A (en) 1999-10-28
SK282621B6 (sk) 2002-10-08
CA2164847C (en) 2005-11-15
JP4054057B2 (ja) 2008-02-27

Similar Documents

Publication Publication Date Title
DE69433161D1 (de) O6-substituierte guaninederivate, verfahren zu ihre herstellung und ihre anwendung für behandlung von tumorzellen
CA2239968A1 (en) Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
ATE240314T1 (de) Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung
ES8401032A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas.
ATE22889T1 (de) 8-chlor-1,5-benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ES473818A1 (es) Procedimiento para preparar derivados de piperazina.
ES8404990A1 (es) Un procedimiento para la preparacion de derivados de prolina.
ES8801649A1 (es) Un procedimiento para preparar fenixialquil(substituido con heterociclo)-isoxazoles y furanos
ATE26716T1 (de) 2-(haloergolinyl)-n'n'-diaethylharnstoff-derivat , verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
ATE59632T1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate
SE8406302D0 (sv) New aminoguanidine derivatives and a process for the preparation thereof
PT81004B (pt) Processo para a preparacao de oxindoles trigiclicos uteis como agentes anti-inflamatorios
YU46675B (sh) Postupak za dobijanje derivata 1-(hidrok-sistirol)-5h- 2,3-benzodiazepina
DK530685A (da) 9-chlor-1,5-benzothiazepinderivater samt fremgangsmaade til fremstilling deraf
ATE42292T1 (de) Imidazo(1,2-c)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
ES8705421A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
DE3769451D1 (de) Indan-derivate, verfahren zu ihrer herstellung und die erhaltenen zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE17484T1 (de) Benzodioxan-imidazolin-verbindungen, verfahren zu deren herstellung und deren anwendung.
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ATE66231T1 (de) Dioxolobenzisoxazolderivate und verfahren zu ihrer herstellung.
ATE28859T1 (de) Derivate von aminonaphthacen und verfahren zu ihrer herstellung.
ES8705433A1 (es) Procedimiento para la preparacion de derivados de piperacina

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: ELDER, RHODERICK HUGH, MANCHESTER, GB

Inventor name: MCCORMICK, JOAN ELIZABETH, DUBLIN 2, IE

Inventor name: MCELHINNEY, ROBERT STANLEY, DUBLIN 2, IE

Inventor name: MCMURRY, THOMAS BRIAN HAMILTON, DUBLIN 2, IE

Inventor name: MARGISON, GEOFFREY PAUL, MANCHESTER, GB

Inventor name: KELLY, JANE, MANCHESTER, GB

Inventor name: RAFFERTY, JOSEPH ANTHONY, MANCHESTER, GB

Inventor name: WATSON, AMANDA JEAN, MANCHESTER, GB

Inventor name: WILLINGTON, MARK ANDREW, MANCHESTER, GB

8339 Ceased/non-payment of the annual fee